Learn about cutting-edge research funded by the Alzheimer's Association, from the researchers themselves.
Free and open to the public.
Tuesday, March 25, 2014,
6:00 – 9:00 p.m.
Registration and light refreshments at 6:00 p.m.
Program begins at 7:00 p.m.
Scottish Rite Masonic Museum & Library (see map)
33 Marrett Road
Lexington, MA 02421
Seating is limited.
Reserve your seat now!
Or call 617.868.6718
Moderated by Brent Forester, MD
Director Mood Disorders Division, Geriatric Psychiatry Research Program and Site Director, Harvard Medical School Psychiatry Core Clerkship, McLean Hospital.
Panel includes members of the MA/NH Medical & Scientific Advisory Committee:
Brad Dickerson, MD
Associate Professor of Neurology, Harvard Medical School, Director of Frontotemporal Disorders Unit, Massachusetts General Hospital
Dan Press, MD
Assistant Professor of Neurology, Harvard Medical School, Clinical Director, Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center
Robert Stern, PhD
Professor of Neurology and Neurosurgery, Boston University School of Medicine, Clinical Core Director of Boston University Alzheimer's Disease Center
Andrew Budson, MD
Professor of Neurology, Boston University School of Medicine, Chief, Cognitive & Behavioral Neurology and Associate Chief of Staff for Education, VA Boston Healthcare System, Memory Disorders Clinic, Associate Director & Education Core Leader, Boston University Alzheimer's Disease Center, Professor of Neurology, Boston University School of Medicine, Lecturer in Neurology, Harvard Medical School
2013 Grant Recipients
2013 New Investigator Research Grant:
Stephen J. Haggarty, PhD.
, is an Associate Professor of Neurology at Harvard Medical School, an Associate in Neuroscience at Massachusetts General Hospital (MGH), Director of the Chemical Neurobiology Laboratory (CGL) within the MGH Center for Human Genetic Research (CHGR), and a Senior Associate member of the Broad Institute of Harvard & MIT.
HDAC1 Activating Compounds as a Novel Therapeutic for Alzheimer's Disease
Stephen J. Haggarty, PhD, and colleagues have developed a series of drug-like compounds that increase the activity of HDAC1; these compounds may protect nerve cells from some conditions that cause cell death. Dr. Haggarty and colleagues have proposed a series of experiments aimed at identifying the best drug-like compound for activating HDAC1.
2013 New Investigator Research Grant:
Tae Ho Lee, PhD
joined the faculty of Beth Israel Deaconess Medical Center and Harvard Medical School as an Assistant Professor in the Division of Gerontology.
Functional Studies of Phosphorylation Regulation in Alzheimer's Disease
Dr. Lee's research focuses on the role of phosphorylation signaling in Alzheimer's disease. The goal is to lead to new insights into Alzheimer's disease and the identification of potential targets for drugs to slow or prevent disease progression.
Wendy Wei Qiao Qiu, MD, PhD
is an Associate Professor in the Psychiatry Department, Pharmacology & Experimental Therapeutics Department, Alzheimer's disease Center (ADC) at Boston University School of Medicine. She is also a faculty member in the Neuroscience Program at Boston University.
Setting Up a Challenge Diagnostic Test for Alzheimer's Disease
Wendy Wei Qiao Qiu, MD, PhD, and colleagues are attempting to develop a diagnostic test for the early stages of Alzheimer's disease These studies could lay the groundwork for a possible blood test for Alzheimer's disease.
2013 Zenith Award
Benjamin Wolozin, MD, PhD
completed his undergraduate education at Wesleyan University in Middletown, CT. He earned his MD and PhD degrees from Albert Einstein College of Medicine, as part of the Medical Scientist Training Program. His postdoctoral fellowships were spent at Mt. Sinai Medical Center (1988–89) and the National Institute of Mental Health (1989–96). He joined the Boston University School of Medicine's Department of Pharmacology in 2004 as a Professor and is currently obtaining an adjunct position in the Dept. of Neurology.